Marksans Pharma Limited (NSE:MARKSANS)
178.58
-5.71 (-3.10%)
Aug 14, 2025, 3:30 PM IST
Marksans Pharma Employees
Marksans Pharma had 1,840 employees as of March 31, 2025. The number of employees increased by 699 or 61.26% compared to the previous year.
Employees
1,840
Change (1Y)
699
Growth (1Y)
61.26%
Revenue / Employee
14.41M INR
Profits / Employee
1.90M INR
Market Cap
80.93B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 1,840 | 699 | 61.26% |
Mar 31, 2024 | 1,141 | 289 | 33.92% |
Mar 31, 2023 | 852 | -38 | -4.27% |
Mar 31, 2022 | 890 | -248 | -21.79% |
Mar 31, 2021 | 1,138 | -12 | -1.04% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Sun Pharmaceutical Industries | 43,000 |
Divi's Laboratories | 10,542 |
Cipla | 30,313 |
Apollo Hospitals Enterprise | 42,497 |
Mankind Pharma | 26,978 |
Zydus Lifesciences | 27,917 |
Fortis Healthcare | 12,237 |
Alkem Laboratories | 18,785 |
Marksans Pharma News
- 3 days ago - Marksans Pharma shares drop 13% as Q1 net profit falls 34.3% YoY to Rs 58.3 crore, revenue down 5% YoY - Business Upturn
- 7 days ago - Marksans Pharma subsidiary gets USFDA final approval for 20 mg Omeprazole Delayed-Release Tablets - Business Upturn
- 6 weeks ago - Marksans Pharma receives EIR from USFDA for Time-Cap Labs facility - Business Upturn
- 2 months ago - Marksans Pharma’s UK subsidiary secures approval for Oxybutynin Hydrochloride oral solution - Business Upturn
- 2 months ago - Marksans Pharma shares jump 3% after large block deal worth Rs 257 crore - Business Upturn
- 2 months ago - Marksans Pharma Block Deal: Over 1 crore shares worth Rs 257 crore change hands at Rs 249.95 per share - Business Upturn
- 2 months ago - Marksans Pharma’s subsidiary Relonchem gets UK MHRA approval for Metformin Hydrochloride Oral Solution - Business Upturn
- 3 months ago - Marksans Pharma’s UK arm gets marketing approval for Sennosides 7.5 mg tablets - Business Upturn